Home›Companies›Healthcare›OpZira

OpZira, Inc.

OpZira makes eye disease detection and monitoring devices for clinicians.

Updated Nov 9, 2026·Latest SEC filing Sep 15, 2026·Suggest an edit

About OpZira

OpZira is a private company based in Middletown, Pennsylvania, incorporated in 2025 in Delaware. It has reported $3,100,000 raised in two offerings on Form D since March 2026. Its chief executive is Clark Tedford.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 9, 2026Sep 15, 2026$2,025,000of $5.0M target11$184KEquityRule 506(b)Form D ↗
Mar 17, 2026Mar 31, 2026$1,075,000target not set6$179KSimple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗
Total, two offerings$3,100,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OpZira's Form D filed Sep 15, 2026.

Clark Tedford
Clark Tedford
President and CEO, director
Also an executive officer and director at LumiThera.
Jackson Streeter
Jackson Streeter
Board Member
Yigang Yang
Yigang Yang
Board Member

Sources

  1. SECOpZira, Inc. filing history
  2. CompanyOpZira contact
  3. CompanyOpZira team